Radiologic Diagnosis in Infants and ChildrenRadiologic Diagnosis in Infants and Children. By BrodeurArmand E., M.D., M.Rd., F.A.C.R., Chief Radiologist, Cardinal Glennon Memorial Hospital for Children, St. Louis, Mo.; Associate Professor of Radiology and Associate Dean, St. Louis University School of Medicine, St. Louis, Mo.; Medical Director, School of X-ray Technology, St. Louis University, St. Louis, Mo.; Chairman, Committee on Public Education, American College of Radiology; Consultant to the Division of Radiological Health of the United States Public Health Service and to The Catholic Hospital Association of the United States and Canada. A volume of 504 pages, with 757 illustrations. Published by the C. V. Mosby Co., St. Louis, Mo., 1965. Price $26.50.

Radiology ◽  
1966 ◽  
Vol 86 (4) ◽  
pp. 753-753
Keyword(s):  
United States ◽  
United States Public Health ◽  
The United States ◽  
Associate Professor ◽  
Radiologic Diagnosis ◽  
X Ray ◽  
School Of Medicine ◽  
Associate Dean ◽  
Radiological Health ◽  
Catholic Hospital

PUBLIC HEALTH

PEDIATRICS ◽  
1960 ◽  
Vol 25 (2) ◽  
pp. 343-347
Author(s):  
George M. Wheatley ◽  
Stephen A. Richardson
Keyword(s):  
Public Health ◽  
United States ◽  
Cause Of Death ◽  
United States Public Health ◽  
The United States ◽  
Vital Statistics ◽  
West Germany ◽  
Medical Attention ◽  
Age Group ◽  
Number Of Children

IN ALL COUNTRIES for which there are vital statistics, accidents are a major cause of death and disability among children. In countries where the food supply is adequate and infectious diseases have been brought under control, accidents have become the leading cause of death in the age group 1 to 19 years. For example, in such countries as Australia, Canada, Sweden, West Germany, and the United States, more than one-third of all deaths in this age group are caused by accidents. The number of children who are injured by accidents fan exceeds the number who are killed. Although no accurate international figures are available, the Morbidity Survey conducted by the United States Public Health Service indicates that in the United States, for every child under 15 killed by accident, 1,100 children are injured severely enough to require medical attention or to be restricted in their activity for at least a day.

scholarly journals Nebulizer – In vitro Bioequivalence testing requirements: A review

1970 ◽  
Vol 8 (1) ◽  
pp. 78-81
Author(s):  
Shubham Prajapati ◽  
Sanjay Saha ◽  
B Shambulingappa ◽  
Dilip Kumar Ch. ◽  
Bikash Sahoo
Keyword(s):  
United States ◽  
Size Distribution ◽  
United States Of America ◽  
Droplet Size Distribution ◽  
The United States ◽  
Drug Substance ◽  
Regulatory Agencies ◽  
Metered Dose ◽  
Radiological Health

Generic Nebulized aerosol is often perceived as inferior to their branded counterparts; however, they are safe and effective if they can meet the regulatory requirements. International regulatory agencies have developed recommendations and guidance for bioequivalence approaches of orally inhaled drug products (OIDPs) for local action. The objective of this article is to discuss the approaches can be used for to show bioequivalence requirement for Food and Drug Administration (FDA) in the United States of America (USA) with reference product. This review endorsed that inhalation solutions and suspensions undertaken to determine the drug substance delivery rate, total drug substance delivered and Aerodynamic assessment of nebulized aerosols [aerodynamic particle size distribution (APSD)/droplet size distribution (DSD)].These are the most important parameters in characterization, evaluation and bioequivalence studies of nebulizers. These devices operate continuously; once loaded and require little or no co-ordination on the part of user they proved that these devices suitable for weak, pediatric or geriatric patients. The regulatory agencies declared that; there is no specific requirements testing in case of nebulizers like Metered dose inhalers (MDI) and Dry powder inhalers (DPIs). In United States of America (USA) regulation falls under the auspices of centre for devices and radiological health (CDRH), and new devices require 510(k) premarket notification. This review outlines all the bioequivalence test parameter.  

Sign in / Sign up

Export Citation Format

Share Document